Literature DB >> 1387343

Inhibition of spontaneous testicular Leydig cell tumor development in F-344 rats by dehydroepiandrosterone.

M S Rao1, V Subbarao, A V Yeldandi, J K Reddy.   

Abstract

The incidence of spontaneous Leydig cell tumors of testis is very high in old F-344 rats. We have examined the effect of dehydroepiandrosterone (DHEA), a steroid hormone with antimitotic and anticarcinogenic properties, on spontaneous Leydig cell tumorigenesis. Fifteen-week-old male F-344 rats were fed a diet containing DHEA (0.45% w/w) for 84 weeks. At the termination of experiment none of the 13 rats had Leydig cell hyperplasia or Leydig cell tumors. All the eight control rats of comparable age had Leydig cell tumors. These findings suggest that DHEA is a potent inhibitor of spontaneous Leydig cell tumors of testis in aged rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387343     DOI: 10.1016/0304-3835(92)90155-o

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

2.  Relationship between serum DHEAS and oxidative stress levels of body mass index in healthy postmenopausal women.

Authors:  Burhan Goy; Murat Atmaca; Mehmet Aslan; Rıfkı Ucler; Murat Alay; Ismet Seven; Halit Demir; Mustafa Ozturk
Journal:  Redox Rep       Date:  2016-02-23       Impact factor: 4.412

3.  Ergosteroids: induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone.

Authors:  H Lardy; B Partridge; N Kneer; Y Wei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

4.  Methionine restriction delays aging-related urogenital diseases in male Fischer 344 rats.

Authors:  Despina Komninou; Virginia L Malloy; Jay A Zimmerman; Raghu Sinha; John P Richie
Journal:  Geroscience       Date:  2019-11-14       Impact factor: 7.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.